Hansa Biopharma AB Share Price London S.E.
Equities
0RC7
SE0002148817
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.56 SEK | +2.88% | +8.39% | +58.85% |
05-21 | Hansa Biopharma to Present Data At 2024 American Transplant Congress Annual Meeting | CI |
04-18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 |
Sales 2024 * | 239M 22.63M 1.77B | Sales 2025 * | 343M 32.42M 2.54B | Capitalization | 2.66B 252M 19.72B |
---|---|---|---|---|---|
Net income 2024 * | -735M -69.54M -5.45B | Net income 2025 * | -712M -67.37M -5.28B | EV / Sales 2024 * | 13.1 x |
Net Debt 2024 * | 474M 44.85M 3.52B | Net Debt 2025 * | 733M 69.39M 5.44B | EV / Sales 2025 * | 9.9 x |
P/E ratio 2024 * |
-3.46
x | P/E ratio 2025 * |
-4.11
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.64% |
Latest transcript on Hansa Biopharma AB
1 day | +2.73% | ||
1 week | +8.39% | ||
Current month | +48.60% | ||
1 month | +47.68% | ||
3 months | +30.71% | ||
6 months | +67.79% | ||
Current year | +58.85% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Tulstrup
CEO | Chief Executive Officer | 59 | 19/03/18 |
Hitto Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 53 | 11-30 |
Achim Kaufhold
CTO | Chief Tech/Sci/R&D Officer | 66 | 28/05/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 28/05/18 | |
Peter Nicklin
CHM | Chairman | 61 | 29/06/22 |
Mats Blom
BRD | Director/Board Member | 59 | 21/05/19 |
Date | Price | Change | Volume |
---|---|---|---|
28/05/24 | 42.56 | +2.88% | 0 |
27/05/24 | 40.25 | -2.71% | 2,493 |
24/05/24 | 41.37 | -4.19% | 7,792 |
23/05/24 | 43.18 | +7.20% | 2,181 |
22/05/24 | 40.28 | +2.59% | 1,949 |
Delayed Quote London S.E., May 28, 2024 at 04:25 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.93% | 63.85B | |
-2.53% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.22% | 26.52B | |
-21.41% | 18.69B | |
+2.62% | 12.73B | |
+22.42% | 12.11B | |
+27.60% | 12.07B |
- Stock Market
- Equities
- HNSA Stock
- 0RC7 Stock